CClinicalTrials.gg
CompletedNCT04370756BEE SWEETUpdated Feb 21, 2024

Beetroot Supplementation in Women Enjoying Exercise Together

An interventional study of Beetroot Juice and Exercise Training in Aging, Postmenopause and Obesity, sponsored by Indiana University. Completed at 1 site in United States. Open to female participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-21.

Sponsored by Indiana University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
Female
01

Study summary

This study seeks to determine the feasibility of an exercise training progression with the consumption of beetroot juice prior to exercise in postmenopausal women. Results from this investigation will be used to determine preliminary effect sizes for exercise training only (control) and exercise training + beetroot juice (EX+BR) to inform the direction of larger randomized clinical trials on pre-post changes in measures of cardiovascular health and endothelial function.

Read the detailed description

An increasing body of evidence has supported acute benefits of beetroot juice including lowered blood pressure and greater muscle oxygenation during exercise. Thus, consumption of beetroot juice prior to exercise may alter the perceptual difficulty for a given exercise bout -- possibly resulting in an individual exercising at a greater intensity (without the commensurate increase in discomfort). The investigators propose that repeated exposure to a relatively greater exercise stimulus (via beetroot juice) may elicit more robust cardio-metabolic adaptations compared to exercise training alone (i.e., without beetroot juice). Possible findings could inform a larger randomized clinical trial to determine if pre-exercise beetroot juice supplementation is an effective strategy to promote health related benefits.

The investigators will examine the effects of pre-exercise beetroot juice coupled with 8 weeks of supervised exercise training among post-menopausal (75 and younger) women. Qualified individuals will be required to complete an initial screening visit as well as three baseline visits (Visits 1-2). Participants will undergo a series of tests including: dual-energy X-ray absorptiometry scan, bioelectrical impedance analysis, exhaled fraction of nitric oxide, health-related questionnaires, and pulse wave velocity. Participants will also be asked to perform leg muscle function and walking tests. Following the completion of Visits 1-2, participants will attend supervised exercise training sessions 3x/week for 8 weeks. Within 2-6 days from the last exercise training session, participants will repeat the same measurement procedures.

The primary objective involves elements of feasibility (e.g., recruitment, retention, adherence, and adverse event) and to generate preliminary effect sizes for 8 weeks of exercise training for two groups: control and EX+BR. Secondary objectives involve preliminary effect sizes for pre-post changes in distance covered during the 6-minute walk test, changes in endothelial-dependent vasodilation, and biomarkers of cardiovascular health.

02

Conditions studied

  • Aging
  • Postmenopause
  • Obesity

Keywords

  • Beetroot juice
  • Postmenopause
  • Exercise training
  • Endothelial function
03

In context

Lead sponsor

Indiana University is the lead sponsor of 958 studies on the registry; 200 are open to participants now.

Of its 142 completed or terminated interventional studies of FDA-regulated products, 112 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Post-menopausal women (self-report)
  • Between the ages of 18-75 years (confirmed by birth date listed on participant's driver license at screening visit)
  • Physician's clearance for study participation (required prior to baseline testing)
  • English-speaking
  • Body mass index between 25.0 to 39.9 kg/m\^2 (measured on-site at screening visit)
  • Able to ambulate without assistance

Exclusion criteria

Exclusion Criteria:

  • Unable to provide informed consent
  • 18-75 of age (confirmed by birth date listed on participant's driver license at screening visit)
  • Body mass index \< 25.0 or >39.9 kg/m\^2 (measured on-site at screening visit)
  • Greater than stage II hypertension (i.e. >159/99 mm Hg)
  • Current smoker (self-report)
  • Currently pregnant, lactating, or trying to become pregnant (self-report)
  • Habitually exercise training >= 3 times per week (self-report)
  • Significant orthopedic limitations or other contraindications to strenuous exercise
  • Live or work >50 miles from Bloomington study site or do not have transportation to the study site
  • Anticipate elective surgery during the study period
  • Plan to move residence or travel out of the local area during the study period
  • History of major metabolic disease (e.g. Type I diabetes, Type II diabetes, thyroid disorders)
  • Current use of anti-coagulants (e.g. Coumadin or Warfarin)
  • Current use of prescription medications that affect heart rate or blood vessel dilation (e.g. phosphodiesterase-5 inhibitors, proton pump inhibitors, systemic adrenergic blockers, nitrates, calcium channel blockers, hormone replacement therapy) (self-report and confirmed on-site at screening visit)
  • Psychological or social characteristic that would interfere with their ability to fully participate in the study (i.e. taking longer than allowed time to complete cognitive assessments)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Ex only

    Participants will perform 8 weeks of supervised exercise training (EX).

    Other: Exercise Training

  • Experimental
    EX + BR

    Participants will perform 8 weeks of supervised exercise training (EX) plus pre-exercise consumption of beetroot juice (BR).

    Dietary Supplement: Beetroot Juice · Other: Exercise Training

Interventions

  • Dietary supplementBeetroot Juice

    Participants randomly assigned to the EX + BR group will consume 140 mL beetroot juice containing approximately 12 mmol of nitrate 3 hours prior to the supervised exercise training component.

  • OtherExercise Training

    Participants will perform 8 weeks of supervised exercise training at a frequency of 3x per week.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    The number of eligible participants randomized per months of recruitment time.

    Time frame: 24 months

  2. Retention rate

    The number of randomized participants who complete at least 17 (out of 24 possible) exercise training sessions.

    Time frame: 8 weeks

  3. Adherence to exercise training intervention

    The percent of exercise sessions attended out of the 24 possible sessions.

    Time frame: 8 weeks

  4. Adherence to dietary nitrate intervention

    Breath analysis of fractional exhaled nitric oxide concentrations.

    Time frame: 8 weeks

  5. Perceived difficulty of training sessions

    Participants will report the perceived exertion at the end of exercise sessions using the Borg category ratio-10 scale that ranges from 0 "no exertion" to 10 "maximal exertion".

    Time frame: 8 weeks

Secondary outcomes

  1. Distance covered during a six-minute walk test

    Participants will be asked to walk as far as possible at a preferred speed for six minutes according to ATS standards. Distance covered will be measured in meters.

    Time frame: Baseline, post-intervention

  2. Soluble endothelial microparticles

    Blood samples will be analyzed for adhesion molecules (sICAM-1, sVCAM-1, sE-selectin).

    Time frame: Baseline, post-intervention

07

Study locations

1 site
  • Indiana University
    Bloomington, Indiana 47401, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Feb 9, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — No IDP sharing plan

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04370756
Lead sponsor
Indiana University
Collaborators
IU Health University Hospital, Indiana CTSI Clinical Research Center, Bloomington Crossfit
Responsible party
Stephen J. Carter, Ph.D. (Assistant Professor, Indiana University) — Principal investigator
First posted
May 1, 2020
Start date
Jan 30, 2020
Primary completion
May 26, 2023
Completion
May 26, 2023
Last update
Feb 21, 2024

Study contacts

Stephen J Carter, Ph.D.
principal investigator · Indiana University, Bloomington

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion